Summary - GENE - NASDAQ - Weiss Ratings

E

Genetic Technologies Limited GENE

$0.765 -$0.015-1.92%

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

--

52-Week Range

$0.6666 - $3.59

P/E (TTM)

--

EPS (TTM)

My Lists My Alerts

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

--

Headlines

Genetic Technologies (NASDAQ:GENE) and#038; Acumen Pharmaceuticals (NASDAQ:ABOS) Financial Survey

12/8/2024 - Ticker Report

Genetic Technologies Defers Reports Amid Administration

12/1/2024 - TipRanks Financial Blog

Genetic Technologies Halts Offers, Returns Funds Amid Compliance Scrutiny

11/29/2024 - TipRanks Financial Blog

Genetic Technologies Enters Voluntary Administration

11/20/2024 - TipRanks Financial Blog

Genetic Technologies Extends Securities Offer Deadline

11/1/2024 - TipRanks Financial Blog

Genetic Technologies Extends Entitlement Offer Deadline

11/1/2024 - TipRanks Financial Blog

Genetic Technologies Extends Offer and Suspends Trading

11/1/2024 - TipRanks Financial Blog

Genetic Technologies Extends Voluntary Suspension for Strategic Moves

10/24/2024 - TipRanks Financial Blog

BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

10/11/2024 - Accesswire

Genetic Technologies Limited (NASDAQ:GENE) Short Interest Update

10/10/2024 - Ticker Report

Genetic Technologies Secures R&D Tax Refund

10/8/2024 - TipRanks Financial Blog

Armistice Capital LLC Takes Position in Genetic Technologies Limited (NASDAQ:GENE)

9/28/2024 - Ticker Report

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2

9/23/2024 - Globe Newswire

Genetic Technologies Extends Share Offer Period

9/17/2024 - TipRanks Financial Blog

Genetic Technologies invited to join CancerIQ online platform

9/11/2024 - The Fly

Genetic Technologies Invited to Join Prestigious CancerIQ Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics

9/11/2024 - Globe Newswire

Genetic Technologies Embraces Capital-Light Model

8/30/2024 - TipRanks Financial Blog

Genetic Technologies Reports Increased Annual Loss

8/30/2024 - TipRanks Financial Blog

Head-To-Head Survey: Genetic Technologies (NASDAQ:GENE) and Vir Biotechnology (NASDAQ:VIR)

8/22/2024 - Ticker Report

Genetic Technologies announces global launch of geneType on EasyDNA platform

8/15/2024 - The Fly

Genetic Technologies Announces Global Launch of geneType on Wholly Owned EasyDNA platform

8/15/2024 - Globe Newswire

Genetic Technologies Launches Exclusive Entitlement Offer

8/12/2024 - TipRanks Financial Blog

Genetic Technologies Launches Shareholder Entitlement Offer

8/12/2024 - TipRanks Financial Blog

Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on August 15

8/9/2024 - Globe Newswire

Genetic Technologies intends to transition to capital light operations model

7/26/2024 - The Fly

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Monday, September 30, 2024

Period Date

Sunday, June 30, 2024

Next Filing

Week of Feb 17 and 21 (est)

Price History

Loading...

Beta

7-Day Total Return

--

30-Day Total Return

--

60-Day Total Return

--

90-Day Total Return

--

Year to Date Total Return

--

1-Year Total Return

--

2-Year Total Return

--

3-Year Total Return

--

5-Year Total Return

--

52-week Low

Oct 02, 2024 - $0.6666

52-week High

Apr 12, 2024 - $3.59

Valuation

Market Cap

$3.60M - Nano Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

--

Dividend Per Share (TTM)

--

Corporate Info

Website

Phone Number

61 3 8412 7000

Address

321 Chapel Street
Level 1 - Suite 7
Prahran, VIC 3181

Country

Year Founded

Business Description

Sector

Industry

Pharmaceuticals, Biotechnology and Life Sciences

Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people’s health in the... more